T
57
3
HON
52
5
TSN
48
2
VFC
38
5
ROP
57
6
NWSA
69
4
BA
33
2
ITW
31
6
AEP
66
5
SJM
31
5
CFG
54
4
FE
60
3
CRM
32
3
INTC
16
-7
DLTR
43
3
IBM
50
6
MCO
64
8
COST
43
2
TSCO
49
5
EFX
55
5
T
57
3
HON
52
5
TSN
48
2
VFC
38
5
ROP
57
6
NWSA
69
4
BA
33
2
ITW
31
6
AEP
66
5
SJM
31
5
CFG
54
4
FE
60
3
CRM
32
3
INTC
16
-7
DLTR
43
3
IBM
50
6
MCO
64
8
COST
43
2
TSCO
49
5
EFX
55
5
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$15.88
Seasonality Move:
6.74%

7 Day Trial

ALL ACCESS PASS

$ 7

He's already IPO'd once - this time's different

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically fallen by 1.5% based on the past 10 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $15.70. The Score for BBC is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically fallen by 1.5% based on the past 10 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Sell
23
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.65
52-Week Low:
13.42

Prediction Charts

Market Cap:
0
Price in USD:
15.70
Volume:
224.7K
Beta:
1.30

Technical Analysis

SMA50:
19.86
SMA100:
22.45
SMA200:
25.21
52-Wk Change:
-44.07%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 15.70 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 20.05 19.36 20.05 19.24
Mar-26 19.31 18.73 19.33 18.59
Mar-27 19.10 19.07 19.16 18.87
Mar-28 19.08 18.66 19.08 18.57
Mar-31 18.23 17.54 18.23 17.29
Apr-1 17.49 16.53 17.49 16.50
Apr-2 16.37 17.25 17.37 16.37
Apr-3 16.63 16.40 16.70 16.17
Apr-4 15.91 15.32 15.99 15.21
Apr-7 14.82 15.04 15.62 14.10
Apr-8 15.67 14.14 15.83 14.00
Apr-9 13.97 15.28 15.68 13.42
Apr-10 14.94 14.84 15.01 14.17
Apr-11 14.92 15.70 15.70 14.73

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.